[1]
|
Mandel, P. and Metais, P. (1948) Comptesrendus des seances de la Societe de biologie etde sesfiliales. Comptesrendus des séances de la Société de biologie et de sesfiliales, 142, 241-243.
|
[2]
|
Haber, D.A. and Velculescu, V.E. (2014) Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA. Cancer Discovery, 4, 650-661. https://doi.org/10.1158/2159-8290.CD-13-1014
|
[3]
|
Cicchillitti, L., Corrado, G., De Angeli, M., et al. (2017) Circulating Cell-Free DNA Content as Blood Based Biomarker in Endometrial Cancer. Oncotarget, 8, 115230-115243. https://doi.org/10.18632/oncotarget.23247
|
[4]
|
Fleischhacker, M. and Schimdt, B. (2007) Circulating Nucleic Acids (CNAs) and Cancer—A Survey. Biochimica et Biophysica Acta, 1775, 181-232. https://doi.org/10.1016/j.bbcan.2006.10.001
|
[5]
|
Jahr, S., Hentze, H., Englisch, S., et al. (2001) DNA Fragments in the Blood Plasma of Cancer Patients: Quantitations and Evidence for their Origin from Apoptotic and Necrotic Cells. Cancer Research, 61, 1659-1665.
|
[6]
|
Stroun, M., Maurice, P., Vasioukhin, V., et al. (2000) The Origin and Mechanism of Circulating DNA. Annals of the New York Academy of Sciences, 906, 161-168. https://doi.org/10.1111/j.1749-6632.2000.tb06608.x
|
[7]
|
Stroun, M., Lyautey, J., Lederrey, C., et al. (2001) About the Possible Origin and Mechanism of Circulating DNA Apoptosis and Active DNA Release. Clinica Chimica Acta, 313, 139-142.
https://doi.org/10.1016/S0009-8981(01)00665-9
|
[8]
|
Canzoniero, J.V. and Park, B.H. (2016) Use of Cell Free DNA in Breast Oncology. Biochimica et Biophysica Acta, 1865, 266-274. https://doi.org/10.1016/j.bbcan.2016.03.006
|
[9]
|
Stotzer, O.J., Lehner, J., Fersching-Gierlich, D., et al. (2014) Diagnostic Relevance of Plasma DNA and DNA Integrity for Breast Cancer. Tumor Biology, 35, 1183-1191. https://doi.org/10.1007/s13277-013-1158-4
|
[10]
|
Lui, Y.Y., Chik, K.W., Chiu, R.W., et al. (2002) Predominant Hematopoietic Origin of Cell-Free DNA in Plasma and Serum after Sex-Mismatched Bone Marrow Transplantation. Clinical Chemistry, 48, 421-427.
https://doi.org/10.1093/clinchem/48.3.421
|
[11]
|
Elshimali, Y.I., Khaddour, H., Sarkissyan, M., et al. (2013) The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients. International Journal of Molecular Sciences, 14, 18925-18958.
https://doi.org/10.3390/ijms140918925
|
[12]
|
Swarup, V. and Rajeswari, M.R. (2007) Circulating (Cell-Free) Nucleic Acids—A Promising, Non-Invasive Tool for Early Detection of Several Human Diseases. FEBS Letters, 581, 795-799. https://doi.org/10.1016/j.febslet.2007.01.051
|
[13]
|
Diaz, L.A. and Bardelli, A. (2014) Liquid Biopsies: Genotyping Circulating Tumor DNA. Journal of Clinical Oncology, 32, 579-586. https://doi.org/10.1200/JCO.2012.45.2011
|
[14]
|
Giacona, M.B., et al. (1998) Cell-Free DNA in Human Blood Plasma: Length Measurements in Patients with Pancreatic Cancer and Healthy Controls. Pancreas, 17, 89-97. https://doi.org/10.1097/00006676-199807000-00012
|
[15]
|
Tsumita, T. and Iwanaga, M. (1963) Fate of Injected Deoxyribonucleic Acid in Mice. Nature, 198, 1088-1089.
https://doi.org/10.1038/1981088a0
|
[16]
|
Lo, Y.M., Zhang, J., Leung, T.N., et al. (1999) Rapid Clearance of Fetal DNA from Maternal Plasma. The American Journal of Human Genetics, 64, 218-224. https://doi.org/10.1086/302205
|
[17]
|
Snyder, M.W., Kircher, M., Hill, A.J., et al. (2016) Cell-Free DNA Comprises an in Vivo Nucleosome Footprint That Informs Its Tissues-of-Origin. Cell, 164, 57-68. https://doi.org/10.1016/j.cell.2015.11.050
|
[18]
|
Nagata, S., Nagase, H., Kawane, K., et al. (2003) Degradation of Chromosomal DNA during Apoptosis. Cell Death & Differentiation, 10, 108-116. https://doi.org/10.1038/sj.cdd.4401161
|
[19]
|
Holdenrieder, S. and Stieber, P. (2004) Apoptotic Markers in Cancer. Clinical Biochemistry, 37, 605-617.
https://doi.org/10.1016/j.clinbiochem.2004.05.003
|
[20]
|
Nagata, S. (2005) DNA Degradation in Development and Programmed Cell Death. Annual Review of Immunology, 23, 853-875. https://doi.org/10.1146/annurev.immunol.23.021704.115811
|
[21]
|
Leon, S.A., Shapiro, B., Sklaroff, D.M., et al. (1977) Free DNA in the Serum of Cancer Patients and the Effect of Therapy. Cancer Research, 37, 646-650.
|
[22]
|
Shapiro, B., Chakrabarty, M., Cohn, E.M., et al. (1983) Determination of Circulating DNA Levels in Patients with Benign or Malignant Gastrointestinal Disease. Cancer, 51, 2116-2120.
https://doi.org/10.1002/1097-0142(19830601)51:11<2116::AID-CNCR2820511127>3.0.CO;2-S
|
[23]
|
Tan, E.M., Schur, P.H., Carr, R.I., et al. (1966) Deoxybonucleic Acid (DNA) and Antibodies to DNA in the Serum of Patients with Systemic Lupus Erythematosus. Journal of Clinical Investigation, 45, 1732-1740.
https://doi.org/10.1172/JCI105479
|
[24]
|
Vasioukhin, V., Anker, P., Maurice, P., et al. (1994) Point Mutations of the N-Ras Gene in the Blood Plasma DNA of Patients with Myelodysplastic Syndrome or Acute Myelogenous Leukaemia. British Journal of Haematology, 86, 774-779. https://doi.org/10.1111/j.1365-2141.1994.tb04828.x
|
[25]
|
Sorenson, G.D., Pribish, D.M., Valone, F.H., et al. (1994) Soluble Normal and Mutated DNA Sequences from Single-Copy Genes in Human Blood. Cancer Epidemiology, Biomarkers & Prevention, 3, 67-71.
|
[26]
|
Lo, Y.M., Corbetta, N., Chamberlain, P.F., et al. (1997) Presence of Fetal DNA in Maternal Plasma and Serum. The Lancet, 350, 485-487. https://doi.org/10.1016/S0140-6736(97)02174-0
|
[27]
|
Rainer, T.H., Wong, L.K., Lam, W., et al. (2003) Prognostic Use of Circulating Plasma Nucleic Acid Concentrations in Patients with Acute Stroke. Clinical Chemistry, 49, 562-569. https://doi.org/10.1373/49.4.562
|
[28]
|
Chang, Y., Chia, R.H., Wu, T.L., et al. (2003) Elevated Cell-Free DNA Detected in Patients with Myocardial Infarction. Clinica Chimica Acta, 327, 95-101. https://doi.org/10.1016/S0009-8981(02)00337-6
|
[29]
|
Frank, O.M. (2016) Circulating Cell-Free DNA Differentiates Severity of Inflammation. Biological Research for Nursing, 18, 477-488. https://doi.org/10.1177/1099800416642571
|
[30]
|
Togneri, F.S., Ward, D.G., Foster, J.M., Devall, A.J., et al. (2016) Genomic Complexity of Urothelial Bladder Cancer Revealed in Urinary cfDNA. European Journal of Human Genetics, 24, 1167-1174.
https://doi.org/10.1038/ejhg.2015.281
|
[31]
|
Birkenkamp-Demtröder, K., Nordentoft, I., Christensen, E., et al. (2016) Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer. European Urology, 70, 75-82. https://doi.org/10.1016/j.eururo.2016.01.007
|
[32]
|
Menon, M.P., Pittaluga, S. and Jaffe, E.S. (2012) The Histological and Biological Spectrum of Diffuse Large B-Cell Lymphoma in the World Health Organization Classification. The Cancer Journal, 18, 411-420.
https://doi.org/10.1097/PPO.0b013e31826aee97
|
[33]
|
李茂, 徐娟, 曹迪, 蒋昱, 徐才刚. 弥漫大B细胞淋巴瘤血浆循环游离DNA水平的动态监测及临床意义[J]. 四川大学学报(医学版), 2018, 49(1): 113-115+139. https://doi.org/10.13464/j.scuxbyxb.2018.01.023
|
[34]
|
王念跃, 马超, 李传燕, 等. 磁性纳米颗粒的制备及在全血DNA提取中的应用[J]. 临床检验杂志, 2016, 34(3): 169-172.
|
[35]
|
Cai, Z., Chen, G., Zeng, Y., Dong, X., et al. (2019) Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma. Clinical Cancer Research, 25, 5284-5294. https://doi.org/10.1158/1078-0432.CCR-18-3477
|
[36]
|
Jiang, P., Chan, C.W., Chan, K.C., et al. (2015) Lengthening and Shortening of Plasma DNA in Hepatocellular Carcinoma Patients. Proceedings of the National Academy of Sciences USA, 112, E1317-E1325.
https://doi.org/10.1073/pnas.1500076112
|
[37]
|
阎其均, 翁羽, 朱付英. 外周血CTCs、cfDNA联合检测在肝癌早期筛查中的应用价值分析[J]. 临床输血与检验, 2020, 22(4): 429-433.
|
[38]
|
黄帅帅, 岑东. 循环游离核酸分子标志物在肾细胞癌诊治中的研究进展[J]. 现代实用医学, 2021, 33(8): 986-989+992.
|
[39]
|
Marur, S. and Forastiere, A.A. (2016) Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clinic Proceedings, 91, 386-396. https://doi.org/10.1016/j.mayocp.2015.12.017
|
[40]
|
Mermod, M., Tolstonog, G., Simon, C., et al. (2016) Extracapsular Spread in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Oral Oncology, 62, 60-71.
https://doi.org/10.1016/j.oraloncology.2016.10.003
|
[41]
|
Mazurek, A.M., Rutkowski, T., Fiszer-Kierzkowska, A., et al. (2016) Assessment of the Total cfDNA and HPV16/18 Detection in Plasma Samples of Head and Neck Squamous Cell Carcinoma Patients. Oral Oncology, 54, 36-41.
https://doi.org/10.1016/j.oraloncology.2015.12.002
|
[42]
|
Wang, Y., Springer, S., Mulvey, C.L., et al. (2015) Detection of Somatic Mutations and HPV in the Saliva and Plasma of Patients with Head and Neck Squamous Cell Carcinomas. Science Translational Medicine, 7, 293ra104.
|
[43]
|
Zhang, W. (2014) TCGA Divides Gastric Cancer into Four Molecular Subtypes: Implications for Individualized Therapeutics. The Chinese Journal of Cancer, 33, 469-470.
|
[44]
|
Chen, W., Zheng, R., Zeng, H. and Zhang, S. (2015) The Updated Incidences and Mortalities of Major Cancers in China, 2011. Chinese Journal of Cancer, 34, 502-507. https://doi.org/10.1186/s40880-015-0042-6
|
[45]
|
Nishida, X. and Hirota, S. (2000) Biological and Clinical Review of Stromal Tumors in the Gastrointestinal Tract. Histology and Histopathology, 15, 1293-1301.
|
[46]
|
Jing, R., Cui, M., Wang, H., et al. (2013) Cell-Free DNA: Characteristics, Detection and Its Applications in Myocardial Infarction. Current Pharmaceutical Design, 19, 5135-5145. https://doi.org/10.2174/1381612811319280012
|
[47]
|
Antonatos, D., Patsilinakos, S., Spanodimos, S., et al. (2006) Cell-Free DNA Levels as a Prognostic Marker in Acute Myocardial Infarction. Annals of the New York Academy of Sciences, 1075, 278-281.
https://doi.org/10.1196/annals.1368.037
|
[48]
|
Snyder, T.M., Khush, K.K., Valantine, H.A., et al. (2011) Universal Noninvasive Detection of Solid Organ Transplant Rejection. Proceedings of the National Academy of Sciences of the United States of America, 108, 6229-6234.
https://doi.org/10.1073/pnas.1013924108
|
[49]
|
Barnett, E.V. (1968) Detection of Nuclear Antigens (DNA) in Normal and Pathologic Human fluids by Quantitative Complement Fixation. Arthritis & Rheumatology, 11, 407-417. https://doi.org/10.1002/art.1780110306
|
[50]
|
Koffler, D., Agnello, V., Winchester, R. and Kunkel, H.G. (1973) The Occurrence of Single-Stranded DNA in the Serum of Patients with Systemic Lupus Erythematosus and Other Diseases. Journal of Clinical Investigation, 52, 198-204.
https://doi.org/10.1172/JCI107165
|
[51]
|
Chen, J.A., Meister, S., Urbonaviciute, V., et al. (2007) Sensitive Detection of Plasma/Serum DNA in Patients with Systemic Lupus Erythematosus. Autoimmunity, 40, 307-310.
|
[52]
|
Truszewska, A., Foroncewicz, B. and Paczek, L. (2017) The Role and Diagnostic Value of Cell-Free DNA in Systemic Lupus Erythematosus. Clinical and Experimental Rheumatology, 35, 330-336.
|
[53]
|
Dunaeva, M., Buddingh, B.C., Toes, R.E., Luime, J.J., Lubberts, E. and Pruijn, G.J. (2015) Decreased Serum Cell-Free DNA Levels in Rheumatoid Arthritis. Autoimmunity Highlights, 6, 23-30.
https://doi.org/10.1007/s13317-015-0066-6
|
[54]
|
Fan, H., Gai, W., Zhang, L., Ma, Y., Wang, H., et al. (2021) Parasite Circulating Cell-Free DNA in the Blood of Alveolar Echinococcosis Patients as a Diagnostic and Treatment-Status Indicator. Clinical Infectious Diseases, 73, e246-e251. https://doi.org/10.1093/cid/ciaa1679
|
[55]
|
Weerakoon, K.G. and McManus, D.P. (2016) Cell-Free DNA as a Diagnostic Tool for Human Parasitic Infections. Trends in Parasitology, 32, 378-391. https://doi.org/10.1016/j.pt.2016.01.006
|
[56]
|
Gal, S., Fidler, C., Turner, S., Lo, Y.M., Roberts, D.J. and Wainscoat, J.S. (2001) Detection of Plasmodium falciparum DNA in Plasma. Annals of the New York Academy of Sciences, 945, 234-238.
https://doi.org/10.1111/j.1749-6632.2001.tb03891.x
|
[57]
|
Ngotho, M., Kagira, J.M., Gachie, B.M., et al. (2015) Loop Mediated Isothermal Amplification for Detection of Trypanosoma brucei Gambiense in Urine and Saliva Samples in Nonhuman Primate Model. BioMed Research International, 2015, Article ID: 867846. https://doi.org/10.1155/2015/867846
|
[58]
|
Chaya, D. and Parija, S.C. (2014) Performance of Polymerase Chain Reaction for the Diagnosis of Cystic Echinococcosis Using Serum, Urine, and Cyst Fluid Samples. Tropical Parasitology, 4, 43-46.
https://doi.org/10.4103/2229-5070.129164
|
[59]
|
Wagner, J. (2012) Free DNA—New Potential Analyte in Clinical Laboratory Diagnostics. Biochemia Medica (Zagreb), 22, 24-38. https://doi.org/10.11613/BM.2012.004
|
[60]
|
Kotsch, K., Mashreghi, M.F., Bold, G., et al. (2004) Enhanced Granulysin mRNA Expression in Urinary Sediment in Early and Delayed Acute Renal Allograft Rejection. Transplantation, 77, 1866-1875.
https://doi.org/10.1097/01.TP.0000131157.19937.3F
|
[61]
|
El Messaoudi, S., Rolet, F., Mouliere, F., et al. (2013) Circulating Cell Free DNA: Preanalytical Considerations. Clinica Chimica Acta, 424, 222-230. https://doi.org/10.1016/j.cca.2013.05.022
|